CFA
IDXX icon

Compass Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Compass Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,248
Closed -$624K – 43
2023
Q1 		$624K Sell
1,248
-4
-0.3% -$1.91K 0.79% 42
2022
Q4 		$511K Hold
1,252
– – 0.69% 50
2022
Q3 		$408K Hold
1,252
– – 0.61% 60
2022
Q2 		$439K Buy
1,252
+2
+0.2% +$816 0.6% 56
2022
Q1 		$684K Buy
1,250
+48
+4% +$25.2K 0.76% 42
2021
Q4 		$791K Buy
+1,202
New +$755K 0.87% 34

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Compass Financial Advisors's IDXX Position: Q2 2023 in Review

Compass Financial Advisors sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 1,248 shares — an estimated $624K sold.

Compass Financial Advisors first reported a position in IDXX in Q4 2021 and held it in 6 quarters. The position peaked at $791K in Q4 2021. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Compass Financial Advisors reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Compass Financial Advisors sold 1,248 Idexx Laboratories shares in Q2 2023, an estimated $624K.
  • Compass Financial Advisors first reported a position in Idexx Laboratories in Q4 2021 and held it in 6 quarters.
  • Compass Financial Advisors's Idexx Laboratories position peaked at $791K in Q4 2021.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Compass Financial Advisors's 13F filing for Q2 2023.